Benjamin Brigant
About
Welcome to my professional space. I am a dedicated and innovative scientist with over 9 years of experience in molecular and cellular biology, specializing in targets identification and regulation. My journey in the field has been marked by a deep commitment to understanding and addressing complex pathologies, ranging from kidney disease to cardiovascular diseases and osteoarthritis, using cutting-edge tools like CRISPR and miRNA. Through my work, I aim to contribute to the groundbreaking advancements in understanding and treating inflammation at the molecular level. Explore my site to learn more about my projects, insights, and the passion that drives my research.
#CRISPR #miRNA #Inflammation #MolecularBiology #CellularBiology
Publications
2024
-
Brigant, Benjamin;
Metzinger-Le Meuth, Valérie;
Boyartchuk, Victor;
Ouled-Haddou, Hakim;
Guerrera, Ida Chiara;
Rochette, Jacques.
(2024)
A proteomic study of the downregulation of TRIM37 on chondrocytes: Implications for the MULIBREY syndrome.
Bone
Academic article
2023
-
Chen, Jerry;
Farraj, Rabih Abou;
Limonta, Daniel;
Tabatabaei Dakhili, Seyed Amir;
Kerek, Evan M.;
Bhattacharya, Ashim.
(2023)
Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease.
Journal of Biological Chemistry
Academic article
Journal publications
-
Brigant, Benjamin;
Metzinger-Le Meuth, Valérie;
Boyartchuk, Victor;
Ouled-Haddou, Hakim;
Guerrera, Ida Chiara;
Rochette, Jacques.
(2024)
A proteomic study of the downregulation of TRIM37 on chondrocytes: Implications for the MULIBREY syndrome.
Bone
Academic article
-
Chen, Jerry;
Farraj, Rabih Abou;
Limonta, Daniel;
Tabatabaei Dakhili, Seyed Amir;
Kerek, Evan M.;
Bhattacharya, Ashim.
(2023)
Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease.
Journal of Biological Chemistry
Academic article